Ignite Creation Date:
2024-05-06 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05943977
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2023-03-22
Brief Title:
A Bioequivalence and Efficacy Study of MB-102 Relmapirazin in Chinese Participants
Sponsor:
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Organization:
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd